STERIS plc

STE is exhibiting a clear Stage 4 decline following a recent support failure, with price extending below key EMAs and accelerating volume on sell-offs. Both medium- and long-term biases are bearish, anchored by lower highs and lower lows. Short-term conditions are oversold but show no exhaustion signal, suggesting further downside is likely. Execution should focus on selling into any pullback or retest of the broken support zone near the 9/20 EMAs and 50 DMA.

• ↑Quarterly dividend hikes to $0.69 mark 21 years of growth.
• ↑Q4 revenue up 9% YoY; FY27 growth guided at 7–8%.
• ↓Tariffs and inflation added ~$55M to FY26 costs, squeezing margins.